Zomedica (ZOMDF) Gains from Sales and Divestitures (2018 - 2026)
Zomedica's Gains from Sales and Divestitures came in at -$96,000 for Q3 2026, compared with -$36,000 a year earlier.
Powered by 
Analysis
Zomedica (ZOMDF) Gains from Sales and Divestitures (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Zomedica reported Gains from Sales and Divestitures of -$138,000; for FY2025, it came in at -$68,000.
- Going back by year, Gains from Sales and Divestitures was -$210,000 in FY2024, $24,000 in FY2023, $1,000 in FY2022 and -$249,000 in FY2021.
- The Q3 2026 figure represents the lowest quarterly Gains from Sales and Divestitures since Q3 2024.
- Business Quant data shows ZOMDF's Gains from Sales and Divestitures at -$2,000 (Q2 2026), -$15,000 (Q1 2026) and -$25,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Zomedica | 97.99 Mn | -87.03 Mn | 6.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -96,000.00 |
| Jun 30, 2026 | -2,000.00 |
| Mar 31, 2026 | -15,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Sep 30, 2025 | -36,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | -37,000.00 |
| Sep 30, 2024 | -134,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 16,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Dec 31, 2021 | -782,000.00 |
| Jun 30, 2021 | 776,000.00 |
| Mar 31, 2021 | -243,000.00 |
| Dec 31, 2020 | 51,200.00 |
| Sep 30, 2020 | 139,668.00 |
API Access
Zomedica Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();